《新股表現》思摩爾國際(06969.HK)暗盤收23.75元 每手賺11,350元
據輝立交易平台顯示,明日掛牌的思摩爾國際(06969.HK)暗盤開市報15.06元,最高見224.3元,收報23.75元,較上市價12.4元,高出91.5%或11.35元,成交3,480萬股,涉資7.89億元。不計手續費,每手1,000股,賬面賺11,350元。
思摩爾國際為霧化科技解決方案提供商,是次公開發售超購115倍,一手中籤率20%,中信証券為獨家保薦人。集資所得約50%會用於提高公司產能;25%將用於在新生產基地實施自動化生產及裝配線;20%將用於投資研發,包括於深圳設立集團級研究院、開發新加熱技術及支付產品認證開支;5%將為運營資金及其他一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.